Home > Publications database > Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1. > print |
001 | 144145 | ||
005 | 20240229112618.0 | ||
024 | 7 | _ | |a 10.1007/s00401-019-02038-4 |2 doi |
024 | 7 | _ | |a pmid:31250151 |2 pmid |
024 | 7 | _ | |a 0001-6322 |2 ISSN |
024 | 7 | _ | |a 1432-0533 |2 ISSN |
024 | 7 | _ | |a altmetric:62899549 |2 altmetric |
037 | _ | _ | |a DKFZ-2019-01694 |
041 | _ | _ | |a eng |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Sievers, Philipp |0 P:(DE-HGF)0 |b 0 |e First author |
245 | _ | _ | |a Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1. |
260 | _ | _ | |a Heidelberg |c 2019 |b Springer |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1573735915_16126 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Rosette-forming glioneuronal tumor (RGNT) is a rare brain neoplasm that primarily affects young adults. Although alterations affecting the mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) signaling pathway have been associated with this low-grade entity, comprehensive molecular investigations of RGNT in larger series have not been performed to date, and an integrated view of their genetic and epigenetic profiles is still lacking. Here we describe a genome-wide DNA methylation and targeted sequencing-based characterization of a molecularly distinct class of tumors (n = 30), initially identified through genome-wide DNA methylation screening among a cohort of > 30,000 tumors, of which most were diagnosed histologically as RGNT. FGFR1 hotspot mutations were observed in all tumors analyzed, with co-occurrence of PIK3CA mutations in about two-thirds of the cases (63%). Additional loss-of-function mutations in the tumor suppressor gene NF1 were detected in a subset of cases (33%). Notably, in contrast to most other low-grade gliomas, these tumors often displayed co-occurrence of two or even all three of these mutations. Our data highlight that molecularly defined RGNTs are characterized by highly recurrent combined genetic alterations affecting both MAPK and PI3K signaling pathways. Thus, these two pathways appear to synergistically interact in the formation of RGNT, and offer potential therapeutic targets for this disease. |
536 | _ | _ | |a 312 - Functional and structural genomics (POF3-312) |0 G:(DE-HGF)POF3-312 |c POF3-312 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
700 | 1 | _ | |a Appay, Romain |b 1 |
700 | 1 | _ | |a Schrimpf, Daniel |0 P:(DE-He78)e54a1e0999c1d8c95869ef9188b794cc |b 2 |u dkfz |
700 | 1 | _ | |a Stichel, Damian |0 P:(DE-He78)d20d08adc992abdb6ccffa1686f1ba17 |b 3 |u dkfz |
700 | 1 | _ | |a Reuss, David E |0 P:(DE-HGF)0 |b 4 |
700 | 1 | _ | |a Wefers, Annika K |0 P:(DE-HGF)0 |b 5 |
700 | 1 | _ | |a Reinhardt, Annekathrin |0 P:(DE-HGF)0 |b 6 |
700 | 1 | _ | |a Coras, Roland |b 7 |
700 | 1 | _ | |a Ruf, Viktoria C |b 8 |
700 | 1 | _ | |a Schmid, Simone |b 9 |
700 | 1 | _ | |a de Stricker, Karin |b 10 |
700 | 1 | _ | |a Boldt, Henning B |b 11 |
700 | 1 | _ | |a Kristensen, Bjarne Winther |b 12 |
700 | 1 | _ | |a Petersen, Jeanette Krogh |b 13 |
700 | 1 | _ | |a Ulhøi, Benedicte P |b 14 |
700 | 1 | _ | |a Gardberg, Maria |b 15 |
700 | 1 | _ | |a Aronica, Eleonora |b 16 |
700 | 1 | _ | |a Hasselblatt, Martin |b 17 |
700 | 1 | _ | |a Brück, Wolfgang |b 18 |
700 | 1 | _ | |a Bielle, Franck |b 19 |
700 | 1 | _ | |a Mokhtari, Karima |b 20 |
700 | 1 | _ | |a Lhermitte, Benoît |b 21 |
700 | 1 | _ | |a Wick, Wolfgang |0 P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee |b 22 |u dkfz |
700 | 1 | _ | |a Herold-Mende, Christel |b 23 |
700 | 1 | _ | |a Hänggi, Daniel |b 24 |
700 | 1 | _ | |a Brandner, Sebastian |b 25 |
700 | 1 | _ | |a Giangaspero, Felice |b 26 |
700 | 1 | _ | |a Capper, David |b 27 |
700 | 1 | _ | |a Rushing, Elisabeth |b 28 |
700 | 1 | _ | |a Wesseling, Pieter |b 29 |
700 | 1 | _ | |a Pfister, Stefan M |0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |b 30 |u dkfz |
700 | 1 | _ | |a Figarella-Branger, Dominique |b 31 |
700 | 1 | _ | |a von Deimling, Andreas |0 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144 |b 32 |u dkfz |
700 | 1 | _ | |a Sahm, Felix |0 P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88 |b 33 |u dkfz |
700 | 1 | _ | |a Jones, David |0 P:(DE-He78)551bb92841f634070997aa168d818492 |b 34 |e Last author |u dkfz |
773 | _ | _ | |a 10.1007/s00401-019-02038-4 |0 PERI:(DE-600)1458410-4 |n 3 |p 497-504 |t Acta neuropathologica |v 138 |y 2019 |x 1432-0533 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:144145 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)e54a1e0999c1d8c95869ef9188b794cc |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)d20d08adc992abdb6ccffa1686f1ba17 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 22 |6 P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 30 |6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 32 |6 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 33 |6 P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 34 |6 P:(DE-He78)551bb92841f634070997aa168d818492 |
913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-312 |2 G:(DE-HGF)POF3-300 |v Functional and structural genomics |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
914 | 1 | _ | |y 2019 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ACTA NEUROPATHOL : 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b ACTA NEUROPATHOL : 2017 |
920 | 1 | _ | |0 I:(DE-He78)B300-20160331 |k B300 |l KKE Neuropathologie |x 0 |
920 | 1 | _ | |0 I:(DE-He78)B320-20160331 |k B320 |l KKE Neuroonkologie |x 1 |
920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l Pädiatrische Neuroonkologie |x 2 |
920 | 1 | _ | |0 I:(DE-He78)B360-20160331 |k B360 |l Pediatric Glioma |x 3 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)B300-20160331 |
980 | _ | _ | |a I:(DE-He78)B320-20160331 |
980 | _ | _ | |a I:(DE-He78)B062-20160331 |
980 | _ | _ | |a I:(DE-He78)B360-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|